Results of Breast-Conserving Therapy for Early Stage Breast Cancer: Kyoto University Experiences

This study evaluated the results of breast-conserving therapy (BCT). Nine hundred six patients who underwent BCT at our hospital between November 1987 and February 1998 were analyzed. The mean age was 48 years. According to the Union Internationale Contre le Cancer 1997 classification system, stages 0, I, IIA, IIB, IIIA, and IIIB were 37, 400, 344, 117, 7, and 1, respectively. Radiation therapy consisted of 50 Gy to the ipsilateral whole breast. Boost irradiation of 10 Gy was administered to 186 of 231 patients with close or positive margins. Nearly all patients received adjuvant chemohormonal therapy with tamoxifen and 5-fluorouracil or its derivatives for 2 years. The minimum and median follow-up periods were 18 and 52 months, respectively. The 5-year overall survival, cause-specific survival, local recurrence-free survival, and disease-free survival rates were 97.3%, 98.4%, 98.1%, and 91.5%, respectively. Local recurrence in preserved breast occurred in 20 patients 7 to 86 months after surgery. Multivariate analysis revealed that the most predictive factor for disease-free survival rates and distant failures was the number of pathologically positive lymph nodes (p < 0.0001), and that the factor for local failure was marginal status (p = 0.005). This study demonstrated that BCT was suitable for the treatment of early-stage breast cancer with its reasonable survival rates and acceptable toxicity.

[1]  서정헌,et al.  반도체 공정 overview , 2001 .

[2]  S G Hilsenbeck,et al.  Significance of axillary lymph node metastasis in primary breast cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  S. Edge,et al.  Treatment of early-stage breast cancer. , 1999, Current problems in cancer.

[4]  M. J. van de Vijver,et al.  Risk factors for local recurrence after breast-conserving therapy for invasive carcinomas: a case-control study of histological factors and alterations in oncogene expression. , 1998, International journal of radiation oncology, biology, physics.

[5]  Umberto Veronesi,et al.  Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes , 1997, The Lancet.

[6]  I. Gage,et al.  Pathologic margin involvement and the risk of recurrence in patients treated with breast‐conserving therapy , 1996 .

[7]  B. Haffty,et al.  Long-term outcome in patients with four or more positive lymph nodes treated with conservative surgery and radiation therapy. , 1996, International journal of radiation oncology, biology, physics.

[8]  A. Recht,et al.  The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. , 1996, The New England journal of medicine.

[9]  R. Arriagada,et al.  Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  I. Gage,et al.  Long-term outcome following breast-conserving surgery and radiation therapy. , 1995, International journal of radiation oncology, biology, physics.

[11]  A. Luini,et al.  Breast conservation is a safe method in patients with small cancer of the breast. Long-term results of three randomised trials on 1,973 patients. , 1995, European journal of cancer.

[12]  P Okunieff,et al.  Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. , 1995, The New England journal of medicine.

[13]  G. Hortobagyi,et al.  Use of tamoxifen for breast cancer: twenty-eight years later. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  M. Hiraoka,et al.  Preliminary results of quadrantectomy and radiation therapy for breast cancer , 1994, Breast cancer.

[15]  M. Hiraoka,et al.  Use of a CT simulator in radiotherapy treatment planning for breast conserving therapy. , 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  D. Neuberg,et al.  Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  B. McCormick.  Selection criteria for breast conservation: The impact of young and old age and collagen vascular disease , 1994, Cancer.

[18]  A. Brahme,et al.  Principles and Practice of Radiation Oncology , 1992 .

[19]  C. Redmond,et al.  Breast tumor recurrence following lumpectomy with and without breast irradiation: an overview of recent NSABP findings. , 1992, Seminars in surgical oncology.

[20]  R. Miralbell,et al.  Radiation therapy and breast conservation: Cosmetic results and complications , 1992 .

[21]  N. Robert,et al.  Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early-stage breast carcinoma. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  F. Vicini,et al.  Radiation pneumonitis in breast cancer patients treated with conservative surgery and radiation therapy. , 1991, International journal of radiation oncology, biology, physics.

[23]  A. Recht,et al.  Edema of the arm as a function of the extent of axillary surgery in patients with stage I-II carcinoma of the breast treated with primary radiotherapy. , 1986, International journal of radiation oncology, biology, physics.

[24]  J. Hendriks,et al.  Histologic multifocality of tis, T1–2 breast carcinomas implications for clinical trials of breast‐conserving surgery , 1985, Cancer.

[25]  S. Schnitt,et al.  Pathologic predictors of early local recurrence in stage I and II breast cancer treated by primary radiation therapy , 1984, Cancer.

[26]  N. Mantel.  Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.

[27]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[28]  Ronin,et al.  Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. , 1995, The New England journal of medicine.

[29]  I. Gage,et al.  Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy. , 1996, Cancer.

[30]  E van der Schueren,et al.  Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial. , 1992, Journal of the National Cancer Institute. Monographs.

[31]  D. Schultz,et al.  Breast recurrence following conservative surgery and radiation: patterns of failure, prognosis, and pathologic findings from mastectomy specimens with implications for treatment. , 1990, International journal of radiation oncology, biology, physics.

[32]  M. Dalinka,et al.  Complications of radiation therapy. , 1985, Critical reviews in diagnostic imaging.

[33]  D.,et al.  Regression Models and Life-Tables , 2022 .